Jalen Hurts' Blood Clots Investigation Outlined By NFL in New Letter to US Senator

The NFL sent more details regarding the upcoming joint review of Philadelphia Eagles quarterback Jalen Hurts' blood clots as well as its protocols for tracking blood clots in response to an inquiry from U.S. Senator Lisa Blunt Rochester, per ESPN's Tim McManus.

"As outlined by the league and NFLPA's Collective Bargaining Agreement, mutually agreed-upon independent medical experts will review the matter and share their conclusions and recommendations with both parties," NFL executive vice president of communications, public affairs and health policy Jeff Miller said in a statement released Friday, via McManus.

"The League and Players Association also have several medical committees that review and monitor player injury data closely," he added. "For at least the past decade, the NFL has tracked clotting disorders among players every season through a subcommittee of its General Medical Committee, and this information is shared with the NFLPA. Following the ongoing joint review, the League and NFLPA will consider appropriate next steps, including whether this case points to a need for additional league-wide guidance."

Hurts was previously ruled out for the remainder of the 2026 NFL season after he was diagnosed with deep vein thrombosis and bilateral pulmonary emboli.

According to Jonathan Jones of The Athletic, Philadelphia's medical staff discovered a superficial blood clot in Hurts' calf after flying to London for a Week 5 matchup with the Jacksonville Jaguars.

Hurts ended up playing against Jacksonville before it was announced that he would be sidelined for the remainder of the year.

The NFL Players Association eventually called for a full investigation of the situation on Oct. 20 before the NFL and NFLPA announced that an investigation would be conducted five days later.

McManus noted Friday that the examination of Hurts and the Eagles by independent medical experts has yet to begin, although the joint review appears to be on the horizon.